Organocatalytic Asymmetric Arylation of p-Quinone Phosphonates: A Green Access to Biaryl Monophosphorus LigandsORGANIC LETTERSIF52021-09-229PRE
η6-Arene CH-O Interaction Directed Dynamic Kinetic Resolution - Asymmetric Transfer Hydrogenation (DKR-ATH) of α-Keto/enol-LactamsADVANCED SYNTHESIS & CATALYSISIF42021-05-288PREAI
Design, Synthesis, and Resolution of Spirocyclic Bisoxindole-Based C2-Symmetric DiolsJOURNAL OF ORGANIC CHEMISTRYIF3.62020-07-218PREAI
Development of an Efficient and Scalable Asymmetric Synthesis of Eliglustat via Ruthenium(II)-Catalyzed Asymmetric Transfer Hydrogenation通过钌 (II) 催化的不对称转移氢化开发高效且可扩展的Eliglustat不对称合成ORGANIC PROCESS RESEARCH & DEVELOPMENTIF3.52019-05-2318PREAI
Development of an Efficient and Scalable Biocatalytic Route to (1S,4R)-8-Hydroxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl Propionate via Enantioselective Enzymatic Desymmetrization of a Prochiral DiesterORGANIC PROCESS RESEARCH & DEVELOPMENTIF3.52019-05-134PREAI
Further Optimization of a Scalable Biocatalytic Route to (3R)-N-Boc-3-aminoazepane with Immobilized ω-TransaminaseORGANIC PROCESS RESEARCH & DEVELOPMENTIF3.52019-02-2110PREAI
3-((R)-4-(((R)-6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic Acid (HEC72702), a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4JOURNAL OF MEDICINAL CHEMISTRYIF6.82018-01-3027PREAI
Stereogenic cis-2-substituted-N-acetyl-3-hydroxy-indolines via ruthenium(ii)-catalyzed dynamic kinetic resolution-asymmetric transfer hydrogenationCHEMICAL COMMUNICATIONSIF4.22018-01-0112PREAI
Identification, Characterization, Synthesis, and Strategy for Minimization of Potential Impurities Observed in the Synthesis of SolithromycinORGANIC PROCESS RESEARCH & DEVELOPMENTIF3.52017-08-023PREAI
Development of an Efficient and Scalable Biocatalytic Route to (3R)-3-Aminoazepane: A Pharmaceutically Important IntermediateORGANIC PROCESS RESEARCH & DEVELOPMENTIF3.52017-03-3126PREAI
Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4)BIOORGANIC & MEDICINAL CHEMISTRYIF32017-02-0152PRE
An Alternative Scalable Process for the Synthesis of the Key Intermediate of OmarigliptinORGANIC PROCESS RESEARCH & DEVELOPMENTIF3.52016-12-0712PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向